Leading Biotech Giants Set Up Shop In China
This article was originally published in PharmAsia News
Executive Summary
Two of the world's leading biotech companies, Biogen Idec and Genzyme, set up branch offices in Shanghai last year. Even as their licensing revenue from multinational pharmaceutical corporations increases, these biotech firms have decided to enter the Chinese market to build up their own sales and distribution networks. Biogen Idec will be investing heavily in China over the next five years while Genzyme plans to set up a plant in Beijing. (Click here for more)